Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026

Pharmacologic data highlight durable GI microbiome modulation, with improvement in epithelial barrier integrity, following SER-155 ...

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Spli…

Superior potency demonstrated versus leading TROP2 ADCs across bladder, lung and breast tumor modelsNovel RNA ...
Le Lézard

Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its ...
AZoSensors

Fast-Tracking Sensor Development with Advanced Lock-in Detection and Control Tools

Cutting-edge tools are accelerating sensor development through precision detection and integrated control systems.
Frontiers

Immunotherapy in Neuroendocrine Tumors: Challenges, Innovations, and Emerging Strategies

Neuroendocrine tumors (NETs) represent a diverse group of neoplasms arising from neuroendocrine cells, most commonly affecting the gastrointestinal tract, ...